Health in Norway

1,135 indicators covering health for Norway.

IndicatorLatest Year10-yr change Rank
Most sold brand of cigarettes - taxes as a % of price - total tax 0.6% 2020 down 13.9% 76th
Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 β€” 109th
Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 β€” 33rd
Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 β€” 41st
Most sold brand of cigarettes - taxes as a % of price - value added 0.2% 2020 unchanged 5th
Most sold brand of cigarettes - taxes as a % of price - specific 0.4% 2020 down 19.2% 38th
Most sold brand of cigarettes - price in US$ at official exchange 14.24 2020 up 7.1% 4th
Number healthy diet unaffordable 100,000 2024 unchanged 128th
Import of environmentally sound technologies 7.28 billion 2020 up 24.4% 34th
Most sold brand of cigarettes - price in PPP$ 13.1 2020 up 40.6% 18th
Export of environmentally sound technologies 3.09 billion 2020 down 26.7% 40th
Pcv3 number unvaccinated 2,753 2023 down 36.0% 111th
Infant mortality 87 2020 down 54.2% 34th
Health risks - Regions β€” Respiratory system diseases mortality crude 78 Per 100 000 inhabitants 2024 up 6.6% 18th
Health risks - Regions β€” Circulatory system diseases mortality crude 181.8 Per 100 000 inhabitants 2024 down 20.7% 35th
Avoidable mortality 8,381 Deaths 2016 down 1.5% 34th
Avoidable mortality β€” Preventable mortality 5,644 Deaths 2016 up 4.3% 31st
Avoidable mortality β€” Treatable mortality 2,737 Deaths 2016 down 11.6% 34th
Reported number of human rabies deaths 0 2023 β€” 62nd
Projected life expectancy by age (in completed years), sex and type 89.5 2100 up 0.9% 7th
Assumptions for mortality rates by age, sex and type of projection 0.0017 2100 down 8.5% 28th
Projected life expectancy by age, sex and type of projection 89.5 2100 up 1.1% 5th
Assumptions for mortality rates by age, sex and type of projection 0.0003 2100 down 29.7% 24th
Projected life expectancy by age (in completed years), sex and type 90 2100 up 0.9% 2nd
Proportion of births delivered in a health facility (Facility births) 99.2% 2022 unchanged 33rd
Life expectancy by age and sex 83.2 2024 up 1.3% 7th
Number of non-autochthonous leprosy cases 0 2024 β€” 47th
Crude death rate hmd 7.95 2024 up 0.9% 32nd
Births and deaths 7.95 2024 up 0.9% 32nd
Period versus cohort life expectancy 83.2 2024 up 1.4% 8th
Annual death rate by age group 2.07 2024 down 14.5% 34th
Number reported cases of cholera 1 2015 unchanged 85th
HPV immunization coverage estimates among primary target cohort (9-14) 91.0% 2025 up 3.4% 16th
Pharmaceutical consumption 342.2 Defined daily dose per 1 000 inhabitants per day 2025 up 26.4% 8th
Life expectancy at birth oecd 83.2 2021 up 2.2% 6th
Risk factors for health β€” Tobacco consumption 11 Cigarettes per smoker per day 2025 down 7.6% 16th
How many health warnings are approved by the law for cigarette 16 2022 unchanged 3rd
Tuberculosis - new and relapse cases 274 2010 up 24.0% 153rd
Number of reported cholera deaths 0 2015 β€” 37th
Physiotherapists 9,160 2023 down 21.2% 24th
Perceived health status 10.3 Percentage of population in the same age 2025 up 60.9% 5th
Health graduates 624 2024 up 10.1% 25th
Health personnel 28,271 2024 up 24.2% 16th
Coverage of the human papillomavirus vaccine 91 2024 up 24.7% 6th
Generalist medical practitioners 5,785 2023 up 30.4% 47th
Percentage of principal display area mandated to be covered by health 35 2022 unchanged 121st
Average of 13 International Health Regulations core capacity scores 99.41 2017 up 6.9% 7th
New cases: pulmonary smear-negative 51 2011 up 41.7% 151st
Hospital beds by function and type of care 17,838 2024 down 9.7% 20th
Percentage of principal display area mandated to be covered by health 30 2022 unchanged 117th
Percentage of principal display area mandated to be covered by health 40 2022 unchanged 114th
Number of full-time equivalent staff in national agency 8 2022 down 42.9% 35th
Total number of notified TB cases 325 2014 up 7.6% 147th
The number of people with susceptibility test result for rifampicin 69 2021 β€” 114th
Specialist medical practitioners 11,701 2023 up 33.5% 44th
Acute care β€” Acute myocardial infarction 30 day mortality 2.4 Per 100 admissions 2023 down 35.1% 28th
Acute care β€” Ischaemic stroke 30 day mortality 3.6 Per 100 admissions 2023 down 23.4% 26th
Acute care β€” Haemorrhagic stroke 30 day mortality 20.4 Per 100 admissions 2023 up 28.3% 15th
New cases: pulmonary smear unknown/not done 83 2011 down 16.2% 64th
Smear-positive tuberculosis treatment-success rate 91.0% 2010 up 30.0% 25th